GSK
LSE:GSK Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 280 Fair Values set on narratives written by author
WA
Consensus Narrative from 20 Analysts
New Vaccines And HIV Advancements Will Shape Future Success
Key Takeaways Strong growth in Specialty Medicines and new product launches expected to drive revenue, particularly in HIV, Respiratory, and Oncology. Expanding portfolio with new vaccines and HIV advancements anticipated to impact earnings and market share positively.
View narrativeUK£17.94
FV
20.3% undervalued intrinsic discount4.24%
Revenue growth p.a.
2users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
24 days ago author updated this narrative